HEALTHSTAT NEWS
Jails are the frontline in fielding dangerous new type of drug withdrawal
A Pennsylvania jail inmate experienced severe withdrawal symptoms from fentanyl laced with medetomidine, a tranquilizer causing extreme complications. Institutions, particularly carceral settings, are struggling to address the treatment gap for this dangerous drug combination.
Related Signal
Adjacent reporting
- Trump 'drug czar' warns of deadly 'rhino tranquilizer' killing Americans as cartel crackdown escalates
- Inside Seattle’s open-air drug crisis as fentanyl ravages city and activists bail out alleged criminals
- Super-Potent Synthetic Opioids Spread Across US Amid Fentanyl Crackdown
- Weapons-grade chemical carfentanil surges as dangerous substitute for fentanyl
- ‘Illicit’ version of fentanyl linked to deadly New Mexico incident that sickened first responders
- Overdoses in L.A. jails fueled by long waits for drug addiction treatment, staffers say